Literature DB >> 10502277

Understanding CNS remyelination: clues from developmental and regeneration biology.

R J Franklin1, G L Hinks.   

Abstract

A guiding principle in remyelination research has been to seek clues to its nature in developmental studies on myelination. This "recapitulation hypothesis" argues that the regenerative response involves rerunning much the same programme as occurs during the developmental process. Here we examine the extent to which current evidence supports this hypothesis and whether this is a useful conceptual framework within which to study remyelination and suggest that an equally fruitful approach is to look to regenerative processes in other tissues. Copyright 1999 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  1999        PMID: 10502277

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  36 in total

Review 1.  Remyelination strategies: new advancements toward a regenerative treatment in multiple sclerosis.

Authors:  Martin Stangel; Corinna Trebst
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

2.  Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro.

Authors:  Neus Franco-Pons; Jordi Tomàs; Bárbara Roig; Carme Auladell; Lourdes Martorell; Elisabet Vilella
Journal:  J Mol Neurosci       Date:  2008-10-04       Impact factor: 3.444

Review 3.  Beyond faithful conduction: short-term dynamics, neuromodulation, and long-term regulation of spike propagation in the axon.

Authors:  Dirk Bucher; Jean-Marc Goaillard
Journal:  Prog Neurobiol       Date:  2011-06-17       Impact factor: 11.685

4.  Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.

Authors:  Sha Mi; Xinhua Lee; Yinghui Hu; Benxiu Ji; Zhaohui Shao; Weixing Yang; Guanrong Huang; Lee Walus; Kenneth Rhodes; Bang Jian Gong; Robert H Miller; R Blake Pepinsky
Journal:  Nat Med       Date:  2011-07-03       Impact factor: 53.440

Review 5.  Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic.

Authors:  Sha Mi; R Blake Pepinsky; Diego Cadavid
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

6.  Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation.

Authors:  Brittney A Beyer; Mingliang Fang; Benjamin Sadrian; J Rafael Montenegro-Burke; Warren C Plaisted; Bernard P C Kok; Enrique Saez; Toru Kondo; Gary Siuzdak; Luke L Lairson
Journal:  Nat Chem Biol       Date:  2017-11-13       Impact factor: 15.040

Review 7.  Remyelinating Pharmacotherapies in Multiple Sclerosis.

Authors:  Riley M Bove; Ari J Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

8.  Thin myelin sheaths as the hallmark of remyelination persist over time and preserve axon function.

Authors:  Ian D Duncan; Rachel L Marik; Aimee T Broman; Moones Heidari
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-24       Impact factor: 11.205

9.  Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.

Authors:  Rina Aharoni; Avia Herschkovitz; Raya Eilam; Michal Blumberg-Hazan; Michael Sela; Wolfgang Bruck; Ruth Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

10.  In vivo quantification of myelin changes in the vertebrate nervous system.

Authors:  Yanming Wang; Chunying Wu; Andrew V Caprariello; Eduardo Somoza; Wenxia Zhu; Changning Wang; Robert H Miller
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.